Seroprevalence of Anti-Hepatitis A Antibody Among 1 - 15 Year Old Children in Kashan-Iran

Authors Information
Article Notes and Dates
To Cite : Taghavi ardakani A, Soltani B, Sehat M, Namjoo S, Haji Rezaei M. et al. Seroprevalence of Anti-Hepatitis A Antibody Among 1 - 15 Year Old Children in Kashan-Iran, Hepat Mon. 2013 ;13(5):e10553. doi: 10.5812/hepatmon.10553.
Abstract
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Rosenthal P. Hepatitis A: a preventable threat. J Pediatr Gastroenterol Nutr. 2002; 35(5): 595-6[PubMed]
  • 2. Davidson LJ, George LE, Kalevitch MV, Rudd DP. Calming the panic over hepatitis A. Nursing. 2004; 34(6): 45-7[PubMed]
  • 3. Su CW, Wu JC, Huang YS, Huo TI, Huang YH, Lin CC, et al. Comparison of clinical manifestations and epidemiology between acute hepatitis A and acute hepatitis E in Taiwan. J Gastroenterol Hepatol. 2002; 17(11): 1187-91[PubMed]
  • 4. Duval B, De Serres G, Ochnio J, Scheifele D, Gilca V. Nationwide canadian study of hepatitis a antibody prevalence among children eight to thirteen years old. Pediatr Infect Dis J. 2005; 24(6): 514-9[PubMed]
  • 5. Charles LT. Hepatitis A in the United States. Pediatr Infec Dis J. 2004; 23(6): 551-2
  • 6. Nada Y, William F. Viral hepatitis. Kliegman Nelson Textbook of Pediatrics. 2011; : 1393-1397
  • 7. Vento S, Garofano T, Renzini C, Cainelli F, Casali F, Ghironzi G, et al. Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C. N Engl J Med. 1998; 338(5): 286-90[DOI][PubMed]
  • 8. Nordenfelt E, Atack W, Al-Kandani S, Al-Nakib W. Hepatitis A in Kuwait. J Kuwait Med Assoc. 1985; 19: 103-108
  • 9. Tapia-Conyer R, Santos JI, Cavalcanti AM, Urdaneta E, Rivera L, Manterola A, et al. Hepatitis A in Latin America: a changing epidemiologic pattern. Am J Trop Med Hyg. 1999; 61(5): 825-9[PubMed]
  • 10. Pinho JR, Sumita LM, Moreira RC, de Souza VA, Saraceni CP, Oba IT, et al. Duality of patterns in hepatitis A epidemiology: a study involving two socioeconomically distinct populations in Campinas, Sao Paulo State, Brazil. Rev Inst Med Trop Sao Paulo. 1998; 40(2): 105-6[PubMed]
  • 11. Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006; 55: 1-23[PubMed]
  • 12. Prevention of hepatitis A infections: guidelines for use of hepatitis A vaccine and immune globulin. American Academy of Pediatrics Committee on Infectious Diseases. Pediatrics. 1996; 98(6 Pt 1): 1207-15[PubMed]
  • 13. Sung JJ. Epidemiology of hepatitis A in Asia and experience with the HAV vaccine in Hong Kong. J Viral Hepat. 2000; 7 Suppl 1: 27-8[PubMed]
  • 14. Kashan meteorological annual report . Director of Meteorology Bureau of Kashan 2012;
  • 15. Mehr AJ, Ardakani MJ, Hedayati M, Shahraz S, Mehr EJ, Zali MR. Age-specific seroprevalence of hepatitis A infection among children visited in pediatric hospitals of Tehran, Iran. Eur J Epidemiol. 2004; 19(3): 275-8[PubMed]
  • 16. Feinstone SM, Kapikian AZ, Purceli RH. Hepatitis A: detection by immune electron microscopy of a viruslike antigen associated with acute illness. Science. 1973; 182(4116): 1026-8[PubMed]
  • 17. Lemon SM. Type A viral hepatitis. New developments in an old disease. N Engl J Med. 1985; 313(17): 1059-67[DOI][PubMed]
  • 18. Cohen JI, Feinstone S, Purcell RH. Hepatitis A virus infection in a chimpanzee: duration of viremia and detection of virus in saliva and throat swabs. J Infect Dis. 1989; 160(5): 887-90[PubMed]
  • 19. Costa-Mattioli M, Monpoeho S, Nicand E, Aleman MH, Billaudel S, Ferre V. Quantification and duration of viraemia during hepatitis A infection as determined by real-time RT-PCR. J Viral Hepat. 2002; 9(2): 101-6[PubMed]
  • 20. Kemmer NM, Miskovsky EP. Hepatitis A. Infect Dis Clin North Am. 2000; 14(3): 605-15[PubMed]
  • 21. Hadler SC, Hollinger FB, Lemon SM, Margolis HS. Viral hepatitis and liver disease. 1991; : 14-20
  • 22. McMahon BJ, Beller M, Williams J, Schloss M, Tanttila H, Bulkow L. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. Arch Pediatr Adolesc Med. 1996; 150(7): 733-9[PubMed]
  • 23. Ataei B, Javadi AA, Nokhodian Z, Kassaeian N, Shoaei P, Farajzadegan Z, et al. HAV in Isfahan province: a population-based study. Trop Gastroenterol. 2008; 29(3): 160-2[PubMed]
  • 24. Kazemi Seyed Alinaghi, Mahram Manoochehr, Koosha Ali, Amirmoghaddami Hamid Reza. Seroprevalence of Hepatitis A in 7-10 year-old children. Iran J Ped. 2007; 17(1)
  • 25. Taghavi SA, Hosseini Asl MK, Talebzadeh M, Eshraghian A. Seroprevalence study of hepatitis A virus in Fars province, southern Iran. Hepat Mon. 2011; 11(4): 285-8[PubMed]
  • 26. Moschen ME, Floreani A, Zamparo E, Baldo V, Majori S, Gasparini V, et al. Hepatitis A infection: a seroepidemiological study in young adults in North-East Italy. Eur J Epidemiol. 1997; 13(8): 875-8[PubMed]
  • 27. Alkhalidi J, Alenezi B, Al-Mufti S, Hussain E, Askar H, Kemmer N, et al. Seroepidemiology of hepatitis A virus in Kuwait. World J Gastroenterol. 2009; 15(1): 102-5[PubMed]
  • 28. Wang SM, Liu CC, Huang YS, Yang YJ, Lei HY. Change in hepatitis A virus seroepidemiology in southern Taiwan: a large percentage of the population lack protective antibody. J Med Virol. 2001; 64(2): 104-8[PubMed]
  • 29. Das K, Jain A, Gupta S, Kapoor S, Gupta RK, Chakravorty A, et al. The changing epidemiological pattern of hepatitis A in an urban population of India: emergence of a trend similar to the European countries. Eur J Epidemiol. 2000; 16(6): 507-10[PubMed]
  • 30. Barzaga BN. Hepatitis A shifting epidemiology in South-East Asia and China. Vaccine. 2000; 18 Suppl 1-4[PubMed]
  • 31. Salehi M, Sanei M. Hepatitis A seroepidemiology in under 30 years old population. J Guilan M Sci. 2005; 10: 37-38
  • 32. de Alencar Ximenes RA, Martelli CM, Merchan-Hamann E, Montarroyos UR, Braga MC, de Lima ML, et al. Multilevel analysis of hepatitis A infection in children and adolescents: a household survey in the Northeast and Central-west regions of Brazil. Int J Epidemiol. 2008; 37(4): 852-61[DOI][PubMed]
  • 33. Werzberger A, Mensch B, Nalin DR, Kuter BJ. Effectiveness of hepatitis A vaccine in a former frequently affected community: 9 years' followup after the Monroe field trial of VAQTA. Vaccine. 2002; 20(13-14): 1699-701[PubMed]
  • 34. Wiedermann G, Kundi M, Ambrosch F, Safary A, D'Hondt E, Delem A. Inactivated hepatitis A vaccine: long-term antibody persistence. Vaccine. 1997; 15(6-7): 612-5[PubMed]
  • 35. Averhoff F, Shapiro CN, Bell BP, Hyams I, Burd L, Deladisma A, et al. Control of hepatitis A through routine vaccination of children. JAMA. 2001; 286(23): 2968-73[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check